Emergent BioSolutions promotes Shofe to executive vice president of corporate affairs

Emergent BioSolutions, a Rockville, Maryland-based specialty pharmaceutical company offering products to address emerging health threats, recently promoted Al Shofe to executive vice president of corporate affairs.

Shofe previously served for the company as senior vice president of corporate affairs since August 2010. Shofe has been with Emergent BioSolutions since 2005, the Hill reports.

Before serving as senior vice president of corporate affairs, Shofe was the company's senior vice president of public affairs between January 2008 and August 2010, vice president of public affairs between May 2007 and January 2008 and vice president of government affairs between 2005 and 2007.

Prior to joining Emergent BioSolutions, Shofe served as director of federal government affairs for Eli Lilly between 2002 and 2005, chief of staff for former Congressman Gil Gutknecht (R-Minn.) between 2001 and 2002 and as head of corporate and regulatory affairs for the Middle East and North African divisions of BAT Industries from 1996 to 2001.

Emergent BioSolutions is a specialty pharmaceutical company seeking to enhance and protect life by developing specialized products for healthcare providers and governments to address health threats and medical needs. Emergent BioSolutions is the developer of BioThrax, the only U.S. Food and Drug Administration-licensed vaccine for the prevention of anthrax disease. Emergent has delivered more than 66 million doses of BioThrax to the U.S. government under active procurement contracts.